The Kinase PKCα Selectively Upregulates Interleukin-17A during Th17 Cell Immune Responses

Immunity

Volumn 38, Issue 1, 2013, Pages 41-52

  Meisel, Marlies ^a   Hermann Kleiter, Natascha ^a   Hinterleitner, Reinhard ^a   Gruber, Thomas ^a   Wachowicz, Katarzyna ^a   Pfeifhofer Obermair, Christa ^a   Fresser, Friedrich ^a   Leitges, Michael ^b   Soldani, Cristiana ^c   Viola, Antonella ^c   Kaminski, Sandra ^a   Baier, Gottfried ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 17; INTERLEUKIN 2; PROTEIN KINASE C ALPHA; SMAD2 PROTEIN; SMAD3 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; INTERFERON INDUCTION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH17 CELL;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION REGULATION; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; PEPTIDE FRAGMENTS; PROTEIN KINASE C-ALPHA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; SUBSTRATE SPECIFICITY; TH17 CELLS;

EID: 84872815448     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.09.021     Document Type: Article

References (63)

1. Abromson-Leeman S., Bronson R.T., Dorf M.E. Encephalitogenic T cells that stably express both T-bet and ROR γ t consistently produce IFNgamma but have a spectrum of IL-17 profiles. J. Neuroimmunol. 2009, 215:10-24.
2. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
3. Axtell R.C., de Jong B.A., Boniface K., van der Voort L.F., Bhat R., De Sarno P., Naves R., Han M., Zhong F., Castellanos J.G., et al. T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010, 16:406-412.
4. Baier G., Wagner J. PKC inhibitors: Potential in T cell-dependent immune diseases. Curr. Opin. Cell Biol. 2009, 21:262-267.
5. Barton A., Woolmore J.A., Ward D., Eyre S., Hinks A., Ollier W.E., Strange R.C., Fryer A.A., John S., Hawkins C.P., Worthington J. Association of protein kinase C α (PRKCA) gene with multiple sclerosis in a UK population. Brain 2004, 127:1717-1722.
6. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
7. Brabletz T., Pfeuffer I., Schorr E., Siebelt F., Wirth T., Serfling E. Transforming growth factor β and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol. Cell. Biol. 1993, 13:1155-1162.
8. Cejas P.J., Walsh M.C., Pearce E.L., Han D., Harms G.M., Artis D., Turka L.A., Choi Y. TRAF6 inhibits Th17 differentiation and TGF-β-mediated suppression of IL-2. Blood 2010, 115:4750-4757.
9. Chang X., Liu F., Wang X., Lin A., Zhao H., Su B. The kinases MEKK2 and MEKK3 regulate transforming growth factor-β-mediated helper T cell differentiation. Immunity 2011, 34:201-212.
10. Chen Y.G., Liu F., Massague J. Mechanism of TGFbeta receptor inhibition by FKBP12. EMBO J. 1997, 16:3866-3876.
11. Chen Y., Yu G., Yu D., Zhu M. PKCalpha-induced drug resistance in pancreatic cancer cells is associated with transforming growth factor-β1. J. Exp. Clin. Cancer Res. 2010, 29:104.
12. +) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011, 34:409-421.
13. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., Lucian L., To W., Kwan S., Churakova T., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
14. El-Behi M., Ciric B., Dai H., Yan Y., Cullimore M., Safavi F., Zhang G.X., Dittel B.N., Rostami A. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011, 12:568-575.
15. Gao P.J., Li Y., Sun A.J., Liu J.J., Ji K.D., Zhang Y.Z., Sun W.L., Marche P., Zhu D.L. Differentiation of vascular myofibroblasts induced by transforming growth factor-β1 requires the involvement of protein kinase Calpha. J. Mol. Cell. Cardiol. 2003, 35:1105-1112.
16. Gruber T., Hermann-Kleiter N., Pfeifhofer-Obermair C., Lutz-Nicoladoni C., Thuille N., Letschka T., Barsig J., Baudler M., Li J., Metzler B., et al. PKC θ cooperates with PKC α in alloimmune responses of T cells in vivo. Mol. Immunol. 2009, 46:2071-2079.
17. Gutcher I., Donkor M.K., Ma Q., Rudensky A.Y., Flavell R.A., Li M.O. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 2011, 34:396-408.
18. Haak S., Croxford A.L., Kreymborg K., Heppner F.L., Pouly S., Becher B., Waisman A. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 2009, 119:61-69.
19. Hermann-Kleiter N., Gruber T., Lutz-Nicoladoni C., Thuille N., Fresser F., Labi V., Schiefermeier N., Warnecke M., Huber L., Villunger A., et al. The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity 2008, 29:205-216.
20. Hirota K., Duarte J.H., Veldhoen M., Hornsby E., Li Y., Cua D.J., Ahlfors H., Wilhelm C., Tolaini M., Menzel U., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 2011, 12:255-263.
21. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., Gold R. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell. Immunol. 2005, 237:123-130.
22. Hymowitz S.G., Filvaroff E.H., Yin J.P., Lee J., Cai L., Risser P., Maruoka M., Mao W., Foster J., Kelley R.F., et al. IL-17s adopt a cystine knot fold: Structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 2001, 20:5332-5341.
23. Ichiyama K., Sekiya T., Inoue N., Tamiya T., Kashiwagi I., Kimura A., Morita R., Muto G., Shichita T., Takahashi R., Yoshimura A. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin. Immunity 2011, 34:741-754.
24. Isakov N., Altman A. Protein kinase C(θ) in T cell activation. Annu. Rev. Immunol. 2002, 20:761-794.
25. Ishigame H., Kakuta S., Nagai T., Kadoki M., Nambu A., Komiyama Y., Fujikado N., Tanahashi Y., Akitsu A., Kotaki H., et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009, 30:108-119.
26. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121-1133.
27. Jäger A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
28. +) T cells. J. Autoimmun. 2011, 37:198-208.
29. Komiyama Y., Nakae S., Matsuki T., Nambu A., Ishigame H., Kakuta S., Sudo K., Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:566-573.
30. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
31. Kurschus F.C., Croxford A.L., Heinen A.P., Wörtge S., Ielo D., Waisman A. Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010, 40:3336-3346.
32. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
33. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., Weaver C.T. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
34. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 2002, 8:500-508.
35. Malhotra N., Robertson E., Kang J. SMAD2 is essential for TGF β-mediated Th17 cell generation. J. Biol. Chem. 2010, 285:29044-29048.
36. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., Hatton R.D., Wahl S.M., Schoeb T.R., Weaver C.T. Transforming growth factor-β induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
37. Martinez G.J., Zhang Z., Chung Y., Reynolds J.M., Lin X., Jetten A.M., Feng X.H., Dong C. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J. Biol. Chem. 2009, 284:35283-35286.
38. Matusevicius D., Kivisäkk P., He B., Kostulas N., Ozenci V., Fredrikson S., Link H. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult. Scler. 1999, 5:101-104.
39. McKarns S.C., Schwartz R.H., Kaminski N.E. Smad3 is essential for TGF-β 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation. J. Immunol. 2004, 172:4275-4284.
40. McQualter J.L., Darwiche R., Ewing C., Onuki M., Kay T.W., Hamilton J.A., Reid H.H., Bernard C.C. Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis. J. Exp. Med. 2001, 194:873-882.
41. Moustakas A., Heldin C.H. Non-Smad TGF-β signals. J. Cell Sci. 2005, 118:3573-3584.
42. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003, 171:6173-6177.
43. + regulatory T cells in the control of experimental CNS autoimmune disease. J. Neuroimmunol. 2008, 193:1-11.
44. Pfeifhofer C., Gruber T., Letschka T., Thuille N., Lutz-Nicoladoni C., Hermann-Kleiter N., Braun U., Leitges M., Baier G. Defective IgG2a/2b class switching in PKC alpha-/- mice. J. Immunol. 2006, 176:6004-6011.
45. Ranganathan P., Agrawal A., Bhushan R., Chavalmane A.K., Kalathur R.K., Takahashi T., Kondaiah P. Expression profiling of genes regulated by TGF-β: Differential regulation in normal and tumour cells. BMC Genomics 2007, 8:98.
46. Saarela J., Kallio S.P., Chen D., Montpetit A., Jokiaho A., Choi E., Asselta R., Bronnikov D., Lincoln M.R., Sadovnick A.D., et al. PRKCA and multiple sclerosis: Association in two independent populations. PLoS Genet. 2006, 2:e42.
47. Shi Y., Massagué J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
48. Takimoto T., Wakabayashi Y., Sekiya T., Inoue N., Morita R., Ichiyama K., Takahashi R., Asakawa M., Muto G., Mori T., et al. Smad2 and Smad3 are redundantly essential for the TGF-β-mediated regulation of regulatory T plasticity and Th1 development. J. Immunol. 2010, 185:842-855.
49. Thomas R.M., Sai H., Wells A.D. Conserved intergenic elements and DNA methylation cooperate to regulate transcription at the il17 locus. J. Biol. Chem. 2012, 287:25049-25059.
50. Tzachanis D., Freeman G.J., Hirano N., van Puijenbroek A.A., Delfs M.W., Berezovskaya A., Nadler L.M., Boussiotis V.A. Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2001, 2:1174-1182.
51. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 2008, 172:146-155.
52. Uyttenhove C., Van Snick J. Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur. J. Immunol. 2006, 36:2868-2874.
53. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
54. Veldhoen M., Hocking R.J., Flavell R.A., Stockinger B. Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 2006, 7:1151-1156.
55. Volpe E., Servant N., Zollinger R., Bogiatzi S.I., Hupé P., Barillot E., Soumelis V. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 2008, 9:650-657.
56. Wieser R., Wrana J.L., Massagué J. GS domain mutations that constitutively activate T β R-I, the downstream signaling component in the TGF-β receptor complex. EMBO J. 1995, 14:2199-2208.
57. Wilson M.S., Madala S.K., Ramalingam T.R., Gochuico B.R., Rosas I.O., Cheever A.W., Wynn T.A. Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 2010, 207:535-552.
58. Yang X.O., Panopoulos A.D., Nurieva R., Chang S.H., Wang D., Watowich S.S., Dong C. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, 282:9358-9363.
59. Yang X.O., Chang S.H., Park H., Nurieva R., Shah B., Acero L., Wang Y.H., Schluns K.S., Broaddus R.R., Zhu Z., Dong C. Regulation of inflammatory responses by IL-17F. J. Exp. Med. 2008, 205:1063-1075.
60. Yang X.O., Pappu B.P., Nurieva R., Akimzhanov A., Kang H.S., Chung Y., Ma L., Shah B., Panopoulos A.D., Schluns K.S., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR α and ROR γ. Immunity 2008, 28:29-39.
61. Yang X.P., Ghoreschi K., Steward-Tharp S.M., Rodriguez-Canales J., Zhu J., Grainger J.R., Hirahara K., Sun H.W., Wei L., Vahedi G., et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 2011, 12:247-254.
62. + T cell lineage differentiation. Immunity 2009, 30:646-655.
63. Zhou H.Y., Chen W.D., Zhu D.L., Wu L.Y., Zhang J., Han W.Q., Li J.D., Yan C., Gao P.J. The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts. J. Vasc. Res. 2010, 47:9-15.